Cargando…
Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy
The standard treatment of locally advanced esophageal cancer comprises multimodal treatment concepts including preoperative chemoradiotherapy (CRT) followed by radical surgical resection. However, despite intensified treatment approaches, 5-year survival rates are still low. Therefore, new strategie...
Autores principales: | Spitzner, Melanie, Emons, Georg, Schütz, Karl Burkhard, Wolff, Hendrik A., Rieken, Stefan, Ghadimi, B. Michael, Schneider, Günter, Grade, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509072/ https://www.ncbi.nlm.nih.gov/pubmed/34638639 http://dx.doi.org/10.3390/ijms221910301 |
Ejemplares similares
-
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2014) -
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
por: Flebbe, Hannah, et al.
Publicado: (2022) -
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017) -
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
por: Koerdel, Kristin, et al.
Publicado: (2021) -
The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012)